Two successful pregnancies in a woman with active acromegaly
Author(s) -
Arnika Szostek,
Jakub Wydra,
Izabella Czajka-Oraniec,
Wojciech Zgliczyński
Publication year - 2020
Publication title -
wiedza medyczna
Language(s) - English
Resource type - Journals
ISSN - 2657-9669
DOI - 10.36553/wm.60
Subject(s) - acromegaly , medicine , pregnancy , pegvisomant , somatostatin , population , pituitary adenoma , gestational diabetes , adenoma , endocrinology , hormone , gestation , growth hormone , environmental health , biology , genetics
Acromegaly is a rare systemic disease, predominantly caused by growth hormone (GH)-secreting pituitary adenoma, leading to insulin-like growth factor-1 (IGF-1) overproduction. Pituitary adenoma extension and/or its treatment can cause infertility or subfertility in both sexes in different mechanisms. Pregnancies in women with active acromegaly are rarely observed but considered generally safe. Growth hormone and IGF-1 concentrations are usually stable during pregnancy and in most cases no significant tumour expansion emerges despite pharmacological therapy withdrawal.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom